Assyro AI

Orange Book product · Brand (NDA)

DOCETAXEL

DOCETAXEL

Brand (NDA)NDA 205934TE APRX SHILPA

At a glance

Dec 22, 2015

Approved

Brand (NDA)

Application

AP

TE code

10

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 22, 2015

    10 yr 8 mo ago

  2. Today

  3. Patent 10842770 expires

    Listed drug product patent expiration.

    Aug 07, 2031

    in 5 yr 3 mo

  4. Patent 8940786 expires

    Listed drug product patent expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  5. Patent 9308195 expires

    Listed drug product patent expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  6. Patent 9763880 expires

    Listed method-of-use patent (U-2561) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  7. Patent 9763880 expires

    Listed method-of-use patent (U-2562) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  8. Patent 9763880 expires

    Listed method-of-use patent (U-2564) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  9. Patent 9763880 expires

    Listed method-of-use patent (U-2560) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  10. Patent 9763880 expires

    Listed method-of-use patent (U-2563) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  11. Patent 9763880 expires

    Listed method-of-use patent (U-2558) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

  12. Patent 9763880 expires

    Listed method-of-use patent (U-2559) expiration.

    Sep 30, 2033

    in 7 yr 5 mo

Pharmaceutical detail

Active ingredient

DOCETAXEL

Strength

80MG/4ML (20MG/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

NDA 205934

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10842770Aug 07, 2031in 5 yr 3 mo
ProductU-2998
8940786Sep 30, 2033in 7 yr 5 mo
ProductU-1789
9308195Sep 30, 2033in 7 yr 5 mo
Product
9763880Sep 30, 2033in 7 yr 5 mo
U-2561
9763880Sep 30, 2033in 7 yr 5 mo
U-2562
9763880Sep 30, 2033in 7 yr 5 mo
U-2564
9763880Sep 30, 2033in 7 yr 5 mo
U-2560
9763880Sep 30, 2033in 7 yr 5 mo
U-2563
9763880Sep 30, 2033in 7 yr 5 mo
U-2558
9763880Sep 30, 2033in 7 yr 5 mo
U-2559
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.